ARTICLE | Product Development
Ebola outbreak exposes treatment gap
WHO prioritizes Zaire-tested mAbs, antivirals as academic labs seek path for strain-specific, pan-Ebolavirus therapies
June 24, 2026 5:35 AM UTC
As the Bundibugyo Ebola outbreak grows in the Democratic Republic of the Congo and Uganda, WHO is trying to fill a therapeutic gap with candidates built largely for other Ebola viruses.
There are no approved vaccines or therapies for Bundibugyo virus...